Application of the MediSense Precision-G Blood Glucose Testing System in a Neonatal Intensive Care Unit

Publisher Website
Google Scholar
Abstract
The ability to perform stat glucose testing in support of a neonatal intensive care unit has traditionally depended on transporting the sample to the central laboratory because most point-of-care glucose analyzers cannot accurately test glucose below 2.22 mmol/L (40 mg/dL). In addition, the high hematocrits commonly encountered in newborns and the high bilirubin concentrations often seen in the neonate can cause major problems with glucose measurements in whole blood. Most glucose meters are used for monitoring the diabetic; thus, their accuracy at low glucose concentrations has not been a prime consideration in their design.